Treatment Alternatives in iSGS (NoAAC PR-02 Study)

Trial ID or NCT#

NCT02481817

Status

not recruiting iconNOT RECRUITING

Purpose

The study is aimed at answering the questions; (1) How well do the most commonly used treatments in iSGS work? and (2) What quality-of-life trade-offs are associated with each approach? With the results of this trial, the investigators hope to provide information to iSGS patients: (1) Given my personal characteristics, conditions, and preferences, what should I expect will happen to me? and (2) What are my options, and what are the potential benefits and harms of these options?

Official Title

Treatment Alternatives in Adult Rare Disease; Assessment of Options in Idiopathic Subglottic Stenosis North American Airway Collaborative PR-02 Study (NoAAC PR-02 Study)

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. * Greater than 18 years of age.* The lesion must involve the subglottis.
Exclusion Criteria:
  1. * Less than 18 years of age* Patients without capacity to consent for themselves* History of significant laryngotracheal traumatic injury.* History of endotracheal intubation or tracheotomy within 2 years of presentation.* Major anterior neck surgery.* History of neck irradiation.* History of caustic or thermal injuries to the laryngotracheal complex.* History of a clinically diagnosed vasculitis or collage vascular disease.* Positive antinuclear cytoplasmic antibody titers.

Contact us to find out if this trial is right for you.

Contact


650-723-5281